D-Pyroglutamic acid

We are D-Pyroglutamic acid CAS:4042-36-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 4042-36-8
Product Name: D-Pyroglutamic acid
Other Name:
D-Pyroglutamic acid
5-oxo-D-proline
(2R)-5-oxopyrrolidine-2-carboxylic acid
L-Pidolic acid
(S)-(-)-2-pyrrolidone-5-carboxylic acid
Pyrrolidonecarboxylic acid
(S)-(-)-γ-Butyrolactam-γ-carboxylic acid
2-Oxo-1-pyrrolidinecarboxylic acid
D-Pyroglutamic Acid
Pyroglutamic acid
L-5-Oxoproline
(S)-(−)-Pyroglutamic acid
(R)-2-Pyrrolidone-5-carboxylic Acid
a-Aminoglutaric Acid Lactam
D-Glutamic Acid Lactam
D-(+)-Pyroglutamic Acid
(S)-(−)-2-Pyrrolidone-5-carboxylic acid
(R)-(+)-2-Pyrrolidinone-5-Carboxylic Acid
(R)-5-Oxopyrrolidine-2-carboxylic Acid
(-)-Pyroglutamic acid
L-Glutamic Acid g-Lactam
 
Density: 1.4±0.1 g/cm3
Boiling Point: 453.1±38.0 °C at 760 mmHg
Melting Point: 155-162ºC
Molecular Formula: C5H7NO3
Molecular Weight: 129.114
Flash Point: 227.8±26.8 °C
Exact Mass: 129.042587
PSA: 66.40000
LogP: -2.39
Vapour Pressure: 0.0±2.4 mmHg at 25°C
Index of Refraction: 1.512
 
Specification
Appearance: White crystal powder
Assay: ≥99.0%
Specific rotation: +10.8~+12.5º 
Loss on drying: ≤0.30%
Cl: ≤0.02%
Fe: ≤10ppm
As: ≤1ppm
Residue on ignition: ≤0.1%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

D-Pyroglutamic acid


Related News: Both patients were being treated in isolation units at a Manila hospital.9-bromo-1-nonanol CAS:55362-80-6 Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.4-(Trifluoromethoxy)anisole Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.2-Bromo-6-nitrophenol Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.The mode of cooperation between domestic API companies and large international companies can lower the export threshold.

Related Products
Product Name
Nalpha-Fmoc-L-lysine Hydrochloride Cas:139262-23-0 View Details
Saccharin View Details
N-Acetylmorpholine View Details
Fmoc-D-2-Nal-OH manufacturer 2,7-Dibromo-9,9-Spiro-Bifluorene manufacturer DMAC-TRZ Cas:1628752-98-6 manufacturer Betamethasone Cas:378-44-9 manufacturer 2-chloro-5-(trifluoromethyl)benzene-1,3-diamine manufacturer